Pregunta:
Rituximab pharma
Autor: SuzukiRespuesta:
Rituximab is infused IV and causes a rapid depletion of B cells (both normal and malignant). The fate of the antibody has not been described.
0 / 5 (0 calificaciones)
1 answer(s) in total
Autor
Suzuki